Background/Objectives: Quercetin is a dietary flavonoid with potential anticancer activity, but comparative effects in malignant and non-malignant lung-derived epithelial cells remain incompletely characterized. Methods: A549 and BEAS-2B cells were exposed to quercetin (1–250 µM) for 24, 48, and 72 h, and MTT-derived cellular metabolic activity was measured. Mean normalized concentration–response curves from three independent biological experiments (n = 3) were fitted with four-parameter logistic models, and Greenhouse–Geisser-corrected cell line × concentration × time interactions were tested. Apoptosis-related gene expression was assessed by qRT-PCR after exposure to 45 µM quercetin for 48 h; 45 µM was not a discrete concentration in the MTT series and was close to the directly tested 40 µM condition. Results: Apparent MTT-derived IC50 values were 58.28 µM (95% CI 44.18–74.81) for A549 and 121.22 µM (89.50–164.66) for BEAS-2B at 48 h, and 2.73 µM (2.31–3.67) and 1.49 µM (1.27–1.77), respectively, at 72 h. Cell line × concentration interactions were significant at all exposure times, as was the cell line × concentration × time interaction; transcriptional profiles differed descriptively between cell lines. Conclusions: The fitted IC50 ordering reversed between 48 and 72 h, so a stable cancer-selective response is not supported. MTT reflects metabolic activity rather than cell death, and transcript changes do not establish functional apoptosis.
No takes yet. Share an insight, caveat, or question.
Vardar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: